Bertram K J, Shipley M T, Ennis M, Sanberg P R, Norman A B
Department of Psychiatry, University of Cincinnati, College of Medicine, Ohio 45267.
Exp Neurol. 1994 Jun;127(2):245-52. doi: 10.1006/exnr.1994.1100.
Both horseradish peroxidase (HRP) and Evans blue dye (EBD) have been used previously to characterize the status of the blood-brain barrier (BBB) within brain tissue transplants and host brain tissue. We investigated the possibility that a differential permeability of the vasculature to these two markers can account for discrepancies in the literature concerning the presence of an intact BBB within the grafted tissues. Intravascular injection of both HRP and EBD was used to evaluate the status of the BBB within intracerebral tissue transplants. Simultaneous injection of HRP and EBD in rats with adrenal medulla transplants or C-6 glioma tumors demonstrated a lack of a BBB within these grafts. Both markers produced consistent results within each tissue type, although HRP was generally a more sensitive marker. In contrast to the lack of a BBB in the C-6 gliomas or adrenal medulla transplants, 1-week-old fetal striatal transplants had a BBB essentially intact to both HRP and EBD. Any reported discrepancies in the characterization of the BBB are not likely due to differences between the properties of HRP or EBD. Fetal striatal transplants appear to have an intact BBB at 1 week following transplantation.
辣根过氧化物酶(HRP)和伊文思蓝染料(EBD)此前均已用于表征脑组织移植和宿主脑组织内血脑屏障(BBB)的状态。我们研究了脉管系统对这两种标志物的不同通透性是否能够解释文献中关于移植组织内完整血脑屏障存在情况的差异。通过血管内注射HRP和EBD来评估脑内组织移植中血脑屏障的状态。在患有肾上腺髓质移植或C-6胶质瘤肿瘤的大鼠中同时注射HRP和EBD,结果显示这些移植组织内不存在血脑屏障。尽管HRP通常是更敏感的标志物,但两种标志物在每种组织类型中都产生了一致的结果。与C-6胶质瘤或肾上腺髓质移植中不存在血脑屏障相反,1周龄胎儿纹状体移植对HRP和EBD的血脑屏障基本完整。任何关于血脑屏障特征描述的差异都不太可能是由于HRP或EBD特性之间的差异所致。胎儿纹状体移植在移植后1周似乎具有完整的血脑屏障。